ABSTRACT CYP2E1 is one of the major cytochrome P450 forms whose expression is strongly inhibited by inflammatory cytokines in humans and rodents. In the present study, we have used the Fao rat hepatoma cell line that constitutively expresses CYP2E1 enzyme to investigate mechanisms of cytokine action. The cells were treated with interleukin (IL)-1␤, tumor necrosis factor-␣ (TNF␣), or IL-6 for 24 or 72 h, and the expression of CYP2E1 was monitored at the transcriptional, mRNA, and protein levels. All three cytokines decreased the CYP2E1 mRNA levels after 24 h, and the effect was even stronger after 72 h. In contrast, significant inhibition of CYP2E1 protein was seen only after 72 h. In transfection assays using a CYP2E1 5Ј Ϫ3685 to ϩ29-luciferase construct, it was found that IL-6 inhibited gene transcription after 24 h, but a similar effect by IL-1␤ and TNF␣ was registered only after 72 h. Using 5Ј deletions of the CYP2E1 5Ј-reporter construct a responsive region for the IL-6 effect was located to Ϫ669 to Ϫ507 base pairs in the CYP2E1 5Ј-flanking region. Interestingly, IL-1␤, but not TNF␣, was found to reduce hepatocyte nuclear factor (HNF)-1␣ binding to the CYP2E1 promotor. However, the transactivation function of HNF-1␣ was found to be impaired in Fao cells. In mouse primary hepatocytes, IL-1␤ decreased HNF-1␣-mediated transactivation. In conclusion, our data indicate that inflammatory cytokines inhibit CYP2E1 expression by multiple mechanisms, including control of HNF-1␣ function and regulation of other transcriptional factors acting on the CYP2E1 5Ј-upstream regulatory region. In addition, regulation of factors of importance for the CYP2E1 mRNA stability may be involved.
Infections and inflammatory stimuli cause a reduction of drug elimination and metabolism of other xenobiotics (Morgan, 1997; Renton, 2001) . The major part of the reduction is believed to be consequence of decreased cytochrome P450 (P450) enzyme levels and activities in liver. Suppression of the major xenobiotic-metabolizing P450 enzymes by different types of infectious diseases or by administration of endotoxin or other types of inflammatory substances to animals, humans, and to cell culture has been observed in numerous studies (Morgan, 1997; Renton, 2001) .
Several mechanisms have been proposed to be involved in down-regulation of P450 enzymes by inflammation. The major hypothesis emphasizes the role of inflammatory cytokines such as interleukin (IL)-6, IL-1, and tumor necrosis factor-␣ (TNF␣), which mediate the induction of acute-phase proteins in liver (Morgan, 1997; Renton, 2001) . Indeed, administration of cytokines such as IL-1␤, TNF␣, IL-6, or interferon-␣ is able to mimic the effects of infections or endotoxin treatment (Singh et al., 1982; Wright and Morgan, 1991; Abdel-Razzak et al., 1993) . Furthermore, use of null mice for certain cytokines or cytokine receptors has been shown to abolish or modify P450 response to inflammatory stimuli (Warren et al., 1999; Siewert et al., 2000) .
Also the role of nitric oxide has been extensively studied (Khatsenko et al., 1993; Carlson and Billings, 1996) . The generation of nitric oxide by inducible nitric-oxide synthase increases during endotoxemia. Nitric oxide is able to react with heme-containing proteins such as P450 enzymes and can decrease P450-mediated activities. Furthermore, nitric oxide may be able to decrease mRNA and protein of at least some forms of cytochrome P450 in the early phase of endotoxemia. However, Morgan and coworkers have shown that endotoxin down-regulates P450 mRNA and protein also in the absence of nitric oxide . Therefore, several mechanisms, including inflammatory cytokines and nitric oxide, may contribute to down-regulation of P450s at various stages and types of inflammation.
CYP2E1 is one of the major P450 forms both in human and rat liver that has been shown to be sensitive to inflammatory stimulus and cytokines both in vivo and in primary hepatocytes (Abdel-Razzak et al., 1993; Morgan et al., 1994; Sindhu et al., 1996; Shedlofsky et al., 2000) . The suppression of CYP2E1 has been detected at the level of mRNA, protein, and catalytic activity and also the systemic elimination of chlorzoxazone, a probe drug for CYP2E1, was decreased in the acute-phase endotoxin response in rats (Rockich and Blouin, 1999) .
In the present study, we have used the Fao rat hepatoma cell line model to study the mechanisms of action of inflammatory cytokines IL-1␤, TNF␣, and IL-6 on expression of CYP2E1. We show that all these major inflammatory cytokines down-regulate CYP2E1 in Fao cells and that multiple mechanisms are involved in the process.
Materials and Methods
Chemicals. Recombinant human cytokines were from the following sources: IL-1␤ (Roche Diagnostics, Mannheim, Germany), TNF␣ (Sigma-Aldrich, St. Louis, MO), and IL-6 (Sigma-Aldrich).
Cell Culture. The Fao rat hepatoma cell line was provided by Dr. Mary Weiss (The Pasteur Institute, Paris, France). The Fao cell line is a differentiated derivative of the H4IIEC3 cell line and expresses a wide spectrum of liver-specific proteins (Deschatrette and Weiss, 1974; Herbst et al., 1991) . This cell line expresses some cytochrome P450 forms and has been used to study the regulation and properties of CYP2E1 (De Waziers et al., 1995; Zhukov and Ingelman-Sundberg, 1999) . The cells were cultured in F-12 Coon's modification medium (Sigma-Aldrich) containing 5% fetal calf serum (Invitrogen, Carlsbad, CA), 100 U/ml penicillin, and 100 g/ml streptomycin (Invitrogen). The medium was changed and the serum was withdrawn 24 h before the experiments. The cytokines were diluted with the cell culture medium and were added at final concentrations of 4 ng/ml IL-1␤, 0.5 ng/ml TNF␣, and 70 ng/ml IL-6. The concentrations were chosen based on previous information in the literature of the effective concentrations in cell culture (Abdel-Razzak et al., 1993) .
Mouse primary hepatocytes were isolated from DBA/2 mouse liver as described previously (Salonpä ä et al., 1994) . Briefly, the mouse liver was perfused with collagenase solution (Worthington Biochemicals, Lakewood, NJ), and the liver cells were collected. After filtration and centrifugation, the isolated hepatocytes were dispersed in William's medium E (Sigma-Aldrich) containing 20 ng/ml dexamethasone (Sigma-Aldrich), insulin-transferrin-sodium selenite media supplement (Sigma-Aldrich) (5 mg/l insulin, 5 mg/l transferrin, and 5 g/l sodium selenate), 10 g/ml gentamicin (Invitrogen), and 10% fetal bovine serum (Invitrogen) at a density of 300,000 cells/one well in 12-well plate. The cultures were maintained at 37°C in humidified incubator for 2 to 3 h, after which nonattached cells were discarded by aspiration, and the medium was replaced by serum-free William's E medium. The cultures were maintained for additional 24 h before transient transfection.
RNA Preparation and Blotting. Total RNA was prepared from Fao cells according to Chomczynski and Sacchi (1987) . Total RNA (20 g) was electrophoretically resolved and transferred to nylon filter. The filters were air-dried and cross-linked by UV exposure. The filters were hybridized with [␣-32 P]dCTP-labeled probes using the standard procedures. Plasmids. The reporter gene constructs were prepared by amplifying the targeted 5Ј-regulatory fragments with polymerase chain reaction and cloning into pGL3-Basic vector (Promega, Madison, WI) in front of a luciferase reporter gene as described previously (Hu et al., 1999) . The constructs were checked by DNA sequencing. The albumin HNF-1␣ cis-acting element is a target to the bacterial Dam DNA methylase (Tronche et al., 1989) , and preparation of albumin constructs in Dam methylase-positive Escherichia coli strain may therefore be used for partial inactivation of the albumin HNF-1␣ element in contrast to the preparation in Dam-negative E. coli. The plasmid DNA used for transfections was purified with Concert highpurity plasmid MaxiPrep system (Invitrogen).
Transfections. The Fao cells were plated a day before transfection to 24-well plates and were approximately 90% confluent at the time of transfection. The CYP2E1 5Ј constructs containing firefly luciferase reporter gene were transfected into the Fao cells using the Lipofectin transfection reagent (Invitrogen) and OptiMEM 1 media (Invitrogen). The pRL-TK plasmid (Promega) containing the Renilla luciferase reporter gene was cotransfected with the CYP2E1 constructs to provide an internal control for the transfection efficiency. The cells were incubated with the DNA-lipid complexes for 24 h after which the medium was replaced with fresh serum-free F-12 Coon's modification media. The cells were treated with cytokine when appropriate and maintained for 24 or 72 h. During 72-h treatments, media were replaced every 24 h and fresh cytokine was added. The reported gene activities were measured with dual luciferase reporter assay system (Promega), and the firefly luciferase activity was normalized against the Renilla luciferase activity. H4IIE cells and primary hepatocytes were transfected with Tfx-20 transfection reagent (Promega) according to the manufacturer's protocol.
Immunoblotting. The Fao cells were washed once with buffer containing 10 mM HEPES, 0.25 M sucrose, pH 7.5 and harvested to the same buffer. The cell suspension was sonicated and centrifuged at 13,000g for 10 min. The pellet was discarded and 15 g of the 13,000g supernatant protein was separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose filter. After completion of transfer, the membrane was dried, resoaked in 50 mM Tris pH 7.5, 0.2 M NaCl, 0.05% Tween 20, blocked in 5% nonfat milk in NaCl/Tris/Tween for 1 h, incubated for 1 h with CYP2E1 antiserum, and then 1 h with protein A-conjugated horseradish peroxidase. The enhanced chemiluminescence method was used for protein visualization (Amersham Biosciences AB, Uppsala, Sweden).
Preparation of Nuclear Extracts. For preparation of nuclear extracts, the Fao cells were harvested to phosphate-buffered saline, spun down at 1,800g for 10 min, and resuspended in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.2 mM PMSF). The cells were pelleted and resuspended again to the hypotonic buffer and homogenized using a glass homogenizer. The nuclei were spun down at 3,300g for 15 min and suspended with low-salt buffer (20 mM HEPES pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 10 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF). KCl (2.5 M) was added drop-wise to a final concentration of 0.4 M, and nuclear proteins were extracted by gentle shaking for 30 min. The nuclei were pelleted at 25,000g for 30 min and the nuclear extract was aliquoted and stored at Ϫ70°C. All steps were carried out at 4°C.
Electrophoretic Mobility Shift Assay. The double-stranded DNA probe (5Ј-TGAAATGATAGCCAACTGCAGCTAATAATAAAC-CAGTAC-3Ј) containing the HNF-1␣ binding site of rat CYP2E1 promoter was labeled with T4 polynucleotide kinase (Amersham Biosciences AB) using [␥- 32 P]ATP. Labeled probe (7 fmol) was incubated with 4.5 g of nuclear extract protein in a final volume of 20 l in a buffer containing 10 mM Tris-HCl pH 7.6, 8 mM HEPES, 14% glycerol, 1 mM EDTA, 0.6 mM MgCl 2 , 125 mM KCl, 1 mM DTT, 0.1 mM PMSF, and 1 g of poly(dI-dC) ⅐ poly(dI-dC). For competition, 25-to 100-fold molar excess of unlabeled probe or mutation probe (5Ј-TGAAATGATAGCCAACTGCACCTAATAACAAAGCAGTAC-3Ј) was used. The identity of the protein components in the retarded complexes was confirmed with antibody specific against HNF-1␣ (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Statistical Analysis. Student's t test was used for comparison between two groups. Comparison of several groups was done with oneway ANOVA followed by least significant difference post hoc test.
Results
Inflammatory Cytokines Inhibit CYP2E1 Expression in Fao Cells. Regulation of CYP2E1 by the inflammatory cytokines IL-1␤, TNF␣, and IL-6 was studied in the rat hepatoma cell line Fao. This cell line constitutively expresses
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CYP2E1 and is therefore a suitable model for this kind of experiment. The cells were maintained in serum-free media and treated with the cytokines for 24 or 72 h until harvested and analyzed for CYP2E1 mRNA and protein contents by RNA and immunoblotting, respectively.
All three cytokines studied caused a decrease of the CYP2E1 mRNA content after 24 h treatment. After 72-h treatment, the effect was even stronger (Fig. 1) . In contrast, the CYP2E1 protein was not decreased after 24-h treatment but only after 72-h treatment (Fig. 2) .
Transcriptional Regulation Is Involved in Inhibition of CYP2E1 Expression Caused by IL-1␤, TNF␣, and IL-6. The involvement of transcriptional regulation in decreased expression on CYP2E1 by the inflammatory cytokines was next studied. A Ϫ3685 to ϩ28 CYP2E1 5Ј-flanking region luciferase reporter construct was transfected into the Fao cells, and the cells were treated with IL-1␤, TNF␣, or IL-6 for 24 or 72 h. Using this reporter construct, it was found that only IL-6 inhibited transcription during the first 24-h treatment, whereas at 72 h significant inhibition was seen after treatment with all cytokines (Fig. 3) .
Regulation of HNF-1␣ by Cytokines. HNF-1␣ plays a major role in activation of CYP2E1 transcription in the rat liver (Liu and Gonzalez, 1995) and is among the several liver-enriched transcription factors that are expressed in the Fao cells (Herbst et al., 1991) . The effect of IL-1␤ and TNF␣ on HNF-1␣ binding to CYP2E1 promoter was studied next.
Fao cells were treated with IL-1␤ or TNF␣ for 72 h or left untreated. The cells were harvested and nuclear extract was prepared and consequently binding of HNF-1␣ to CYP2E1 promoter HNF-1␣ element was measured by electrophoretic mobility shift assay. Two specific bands were detected that were competed away by 25-to 100-fold excess of unlabeled HNF-1␣ oligonucleotides. However, mutation of the nucleotides known to be important for HNF-1␣ binding abolished competition. The correct identity of the bands was confirmed by supershifting with HNF-1␣-specific antibody. IL-1␤ treatment clearly reduced HNF-1␣ binding to CYP2E1 promoter element, whereas TNF␣ had no effect (Fig. 4) .
HNF-1␣ Does Not Transactivate CYP2E1 in Fao Cells. We have previously shown that the major segments mediating the transcriptional activation of CYP2E1 gene in Fao cell lie within the proximal 500 bp of the 5Ј-flanking region (Hu et al., 1999) . To analyze the function of the proximal promoter and search for targets of the cytokine effect, we prepared a series of CYP2E1 5Ј-flanking region-luciferase reporter plasmids and transfected these constructs into Fao cells (Fig. 5) . The highest activation of transcription was produced by the longest Ϫ507 to ϩ28 construct, i.e., 70-fold activation compared with the no promoter containing pGL3-basic plasmid. 5Ј deletion to Ϫ183 caused 2.2-fold decrease of the luciferase activity, indicating localization of activating elements within the region between Ϫ507 and Ϫ183. Surprisingly, further 5Ј deletion to Ϫ41 bp had only minor effect to the luciferase activity. Therefore, Ϫ41 to ϩ28, TATA box-containing, minimal construct was responsible for a significant proportion of the total activation of CYP2E1 transcription in Fao cells and produced 48-fold higher luciferase activity than the no promoter containing pGL3-Basic construct.
Deletion of the HNF-1␣ binding site, believed to be the major activator of the CYP2E1 transcription in rat liver, did not reduce the transcription but had a slight opposite effect. To further analyze the function of HNF-1␣ in the Fao cell line, we constructed a collection of reporter plasmids for this purpose. The HNF-1␣ element was linked directly to the CYP2E1 core promoter as a single or in three copies. These elements produced, however, no activation in Fao cells (Fig.  5) . We next studied whether inability of HNF-1␣ to activate transcription was a phenomenon specific for CYP2E1 promoter or a more general failure of HNF-1␣ transactivation function in Fao. HNF-1␣ element containing albumin construct was prepared both in Damϩ and DamϪ E. coli, and also a HNF-1␣ deletion construct was made and transfected into Fao cells as well as into H4IIE cells. In H4IIE cells, the Ϫ93-bp albumin promoter activated pGL3 basic construct 15-fold and both deletion or Dam methylation of the HNF-1␣ site diminished the transcription indicating functional HNF-1␣ (Fig. 6) . In contrast, in Fao cells deletion or methylation of the albumin HNF-1␣ sequence had no effect, indicating that in the Fao cell line HNF-1␣ is incapable of activating transcription (Fig. 5) .
Effect of IL-1␤ on HNF-1␣-Mediated Transcriptional Activation in Primary Hepatocytes.
To further assess the functional consequences of reduction of HNF-1␣ binding to CYP2E1 promoter by IL-1␤ in a model system with intact HNF-1␣, we used mouse primary hepatocyte cultures. Luciferase reporter construct with three copies of HNF-1␣ elements attached to CYP2E1 core promoter of just core promoter alone were transfected to hepatocytes, and the cells were treated with IL-1␤ for 24 h. The HNF-1␣ elements activated transcription 4.7-fold compared with the CYP2E1 core promoter alone. IL-1␤ decreased transcription of HNF-1␣-containing construct by 40% but had no statistically significant effect on CYP2E1 core promoter alone (Fig. 7) .
Localization of the Cytokine-Regulated Elements in the CYP2E1 Promoter. To further characterize the mechanisms involved in depression of CYP2E1 transcription, a series of reporter constructs with different length of 5Ј deletions were transfected to Fao cells and the cells were treated with different cytokines. The results of this deletion analysis are summarized in Figs. 8 and 9 . IL-1␤ and TNF␣ had very similar effects on the luciferase activity produced by the different constructs, suggesting that they both regulate CYP2E1 transcription through an analogous mechanism. For both cytokines, the major effect was localized at the very proximal promoter but some additional effect was seen using the longer constructs. In contrast, it was found that IL-6 did not affect the proximal promoter but acted through a more distal regulatory element located between Ϫ669 and Ϫ507 bp.
Discussion
The inflammatory cytokines IL-1␤, TNF␣, and IL-6 were found to suppress CYP2E1 expression in Fao rat hepatoma jpet.aspetjournals.org cell line in a similar manner as observed previously in primary hepatocytes (Abdel-Razzak et al., 1993) . The Fao cell line therefore seemed to be a useful model system for the study of CYP2E1 regulation by inflammatory cytokines. Several potential mechanisms for CYP2E1 suppression were revealed. IL-6 was shown to inhibit CYP2E1 expression at the transcriptional level. Late transcriptional suppression by IL-1␤ and TNF␣ was preceded by early decrease in the CYP2E1 mRNA levels. IL-1␤ was found to down-regulate HNF-1␣ binding to the CYP2E1 promoter. However, the function of HNF-1␣ was apparently impaired in the Fao cells compared with H4IIE cells, and the effect on HNF-1␣ by IL-1␤ could not explain the inhibition of CYP2E1 expression found in the Fao cells, but may well be an important mechanism for the IL-1␤-dependent transcriptional control of the hepatic CYP2E1 gene in vivo. Indeed, IL-1␤ was able to decrease HNF-1␣-mediated activation of transcription in mouse primary hepatocyte culture system.
The overall regulation of CYP2E1 expression is very complex and involves, as emphasized, multiple mechanisms at different levels. The constitutive level of hepatic CYP2E1 is regulated transcriptionally by liver-enriched transcription factors, especially by HNF-1␣ (Ueno and Gonzalez, 1990) . Pathophysiological conditions such as diabetes regulate CYP2E1 expression by affecting RNA stability (Song et al., 1987; De Waziers et al., 1995) . On the other hand, exogenous compounds mainly regulate CYP2E1 at post-translational level by stabilizing the protein (Roberts et al., 1995) . There is little evidence for transcriptional induction of CYP2E1 by xenobiotics and only few examples of such physiological conditions exist. These include starvation (Johansson et al., 1990 ) and interleukin-4 stimulation (Lagadic-Gossmann et al., 2000) , but the exact mechanism of induction is still unclear.
The Fao cell line is one of the very rare hepatoma cell lines constitutively expressing CYP2E1, and it has been used in several studies to investigate the CYP2E1 regulation (De Waziers et al., 1995; Simi and Ingelman-Sundberg, 1999; Zhukov and Ingelman-Sundberg, 1999 ). In the current study, however, we show that there are important differences in the regulatory mechanisms of CYP2E1 between the Fao cells and the rat liver. HNF-1␣ is clearly involved in activation of CYP2E1 transcription in the liver (Ueno and Gonzalez, 1990; Liu and Gonzalez, 1995) . However, we found that HNF-1␣ failed to activate CYP2E1 transcription in the Fao cells and that other factors contribute to the transcriptional activity in the Fao cells. The functional defect of HNF-1␣ in the Fao may explain the relative low expression level of CYP2E1 in these cells. The mechanism of HNF-1␣ functional impairment in Fao cells is unknown. We show that the HNF-1␣ is expressed in Fao cells, able to bind at a specific DNA binding site and therefore also presents normal dimerization function. However, the Fao cells could lack the dimerization cofactor HNF-1␣ (DcoH), which does not change DNA binding characteristics of HNF-1␣, but affects transcriptional activation (Hansen and Crabtree, 1993) or necessary coactivators could be absent. HNF-1␣ binding to its cognate response elements has previously been shown to be reduced by LPS and HNF-1␣ is probably involved in inflammatory repression of some genes such as ntcp and CYP27A (Trauner et al., 1998; Memon et al., 2001) . Here, we show that IL-1␤ is able to decrease HNF-1␣ binding to the CYP2E1 promoter. This finding is in agreement with a recent investigation showing decreased HNF-1␣ binding to the CYP2E1 promoter after lipopolysaccharide treatment of rats (Roe et al., 2001) . The functional consequence of decreased HNF-1␣ binding could not be studied in Fao cells. Instead, we show in mouse primary hepatocytes that IL-1␤ treatment also affects transactivation by HNF-1␣, suggesting that HNF-1␣ inhibition is one of the mechanisms involved in CYP2E1 suppression by inflammation and is mediated by IL-1␤.
Although IL-1␤-mediated HNF-1␣ down-regulation may be implicated in decreased CYP2E1 expression in liver, additional mechanisms clearly exist and predominate in HNF-1␣-impaired Fao cell line. IL-1␤ and TNF␣ had very similar effect on the CYP2E1 transcription. They both affected even very short promoter constructs of only up to Ϫ40 bp, but additional effects were seen with longer constructs up to Ϫ3685 bp, suggesting contribution of multiple transcription factors. Nevertheless, the effect on CYP2E1 transcription was not detectable after 24-h treatment when CYP2E1 mRNA was already decreased. The primary mechanism of CYP2E1 mRNA down-regulation is thus post-transcriptional or alternatively could require elements not present in the 3685-bp construct used. The attempts to analyze involvement of putative post-transcriptional mechanism by measuring the mRNA half-life were unsuccessful because of the mRNA concentrations rapidly dropped to concentrations lower than the sensitivity limit of the assay.
IL-6 efficiently decreased CYP2E1 protein and mRNA. In contrast to IL-1␤ and TNF␣, the CYP2E1 mRNA decrease was accompanied by an early decrease in transcriptional activity, suggesting predominance of transcriptional inhibition by IL-6. The sequence mediating the IL-6 effect was localized to Ϫ669 to Ϫ507 bp of the CYP2E1 5Ј-upstream regulatory region. According to our previous studies, this region does not contain activating elements but instead is target for repressors (Hu et al., 1999) . IL-6 could affect binding of one these factors or induce binding of new repressing proteins. The major transcription factors mediating IL-6 effects include NF-IL-6 (C/EBP ␤) and STAT3 (Akira, 1997) . The MatInspector professional search (http://transfac.gbf.de/ (Wingender et al., 2000) failed, however, to reveal any NF-IL-6 or STAT3 binding sites at Ϫ669 to Ϫ507 area of CYP2E1 5Ј-flanking region, suggesting that other factors mediate the IL-6 effect on CYP2E1 expression. The previous information in the literature did not suggest involvement of IL-6 in the reduction of HNF-1␣ binding by inflammation (Green et al., 1996; Trauner et al., 1998) and our transfection studies suggested that the mechanism of IL-6 action is mediated by sequences upstream from the CYP2E1 HNF-1␣ site. Therefore, the effect of IL-6 on HNF-1␣ binding to the CYP2E1 promoter was not studied.
The reduction of P450-mediated drug metabolism during inflammation has been well established (Shedlofsky et al., 1994; Morgan, 1997) . The involvement of inflammatory cytokines in this process is also well recognized. Yet, the molecular mechanisms mediating the effects of inflammatory cytokines on P450 enzymes are still poorly understood. Recently, it was shown that nuclear factor-B is involved in suppression of rat CYP2C11 transcription by binding to the transcription start site (Iber et al., 2000) . In the current study, we show that CYP2E1 is regulated by inflammatory cytokines by a number of mechanisms. Different cytokines differently affect individual P450 forms and even the same cytokine may act on various signal transduction pathways. Therefore, it is plausible that a number of mechanisms, both direct and indirect, are involved in the down-regulation of P450 enzymes by inflammatory cytokines and thus no single mechanism may explain suppression of all P450 forms. In fact, each P450 gene may have a unique way of regulation by inflammatory cytokines.
In conclusion, our results indicate that the CYP2E1 downregulation by inflammation is mediated by several cytokines and by multiple regulatory pathways. These include the control of transcription factors such as HNF-1␣ known to mediate CYP2E1 constitutive expression, effects through other transcriptional factors acting on specific elements in the CYP2E1 5Ј-upstream regulatory region, and possibly regulation of factors of importance for the CYP2E1 mRNA stability. This is in agreement with recent studies using null mice showing that the absence of individual cytokines modulate but do not abolish the effect of endotoxin on CYP2E1 expression (Warren et al., 1999; Siewert et al., 2000) .
